[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
[ Thu, Mar 09th 2023 ]: WOPRAI
Hartaj Singh Maintained (SRPT) at Buy with Decreased Target to $150 on, Mar 9th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Hartaj Singh of Oppenheimer, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Decreased Target from $180 to $150 on, Mar 9th, 2023.
Hartaj has made no other calls on SRPT in the last 4 months.
There are 12 other peers that have a rating on SRPT. Out of the 12 peers that are also analyzing SRPT, 1 agrees with Hartaj's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Judah Frommer of "Credit Suisse" Maintained at Hold with Increased Target to $144 on, Wednesday, March 1st, 2023
These are the ratings of the 11 analyists that currently disagree with Hartaj
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $206 on, Friday, March 3rd, 2023
- Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $226 on, Wednesday, March 1st, 2023
- Brian Skorney of "Baird" Maintained at Buy with Increased Target to $202 on, Wednesday, March 1st, 2023
- Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $187 on, Wednesday, March 1st, 2023
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $190 on, Wednesday, March 1st, 2023
- Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy with Increased Target to $171 on, Wednesday, March 1st, 2023
- Gil Blum of "Needham" Maintained at Strong Buy with Increased Target to $200 on, Wednesday, March 1st, 2023
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy and Held Target at $160 on, Tuesday, February 28th, 2023
- Joseph Schwartz of "SVB Leerink" Reiterated at Buy and Held Target at $160 on, Friday, January 20th, 2023
- Yun Zhong of "BTIG" Maintained at Strong Buy with Increased Target to $160 on, Thursday, December 22nd, 2022
- Colin Bristow of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $158 on, Friday, December 16th, 2022